CTCF and prostate intraepithelial neoplasia: (2017) described a mouse model with loss‐of‐function mutations of the CTCF‐binding site at the IGF2‐H19 imprint control region, which resulted in bi‐allelic IGF2 expression and increased prevalence of prostatic intraepithelial neoplasia (PIN).